JNM review: Where will PET/MR prove most useful?

03/19/2013 | MolecularImaging.net

PET/MR has come a long way since 2007, when the first device integrating both technologies was developed, according to a paper published in The Journal of Nuclear Medicine. "Given the complementary nature of each modality's strengths and weaknesses, integrating PET and MR imaging offers the opportunity to gain in a single examination many of the positive attributes of both and mitigate some of their limitations," researchers said. PET/MR has shown it can improve imaging of cancers of the head and neck as well as the pelvis, and the approach is useful for non-malignant growths, the study said. PET/MR is also showing future potential for imaging neuropsychiatric conditions and Alzheimer's disease, and it can be useful in patients whose radiation exposure must be limited.

View Full Article in:

MolecularImaging.net

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC